Structure of Eculizumab
CAS No.: 219685-50-4
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Eculizumab is a humanized IgG2/4 monoclonal antibody that prevents complement system activation by binding to C5. Eculizumab has potential for research in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
Synonyms: Anti-Human C5, Humanized Antibody
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 219685-50-4 |
M.W : | 145.74 kDa |
SMILES Code : | NONE |
Synonyms : |
Anti-Human C5, Humanized Antibody
|
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319 |
Precautionary Statements: | P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT01567085 | Stage V Chronic Kidney Disease | PHASE2 | COMPLETED | 2017-05-24 | Adelaide, 5000, Australia|Camp... More >>erdown, 2050, Australia|Parkville, 3050, Australia|Bordeaux, 33076, France|Paris, 75010, France|Paris, 75743, France|Toulouse, 31059, France|Tours, 37044, France|Brescia, 25123, Italy|Padova, 35128, Italy|Barcelona, 08907, Spain|Gothenburg, 413 45, Sweden|Uppsala, 751 85, Sweden|Cambridge, CB2 2QQ, United Kingdom|London, SE1 9RT, United Kingdom Less << |
NCT01221181 | Dense Deposit Disease|Membrano... More >>proliferative Glomerulonephritis Less << | PHASE1 | COMPLETED | 2025-10-11 | Columbia University Medical Ce... More >>nter, Glomerular Center, New York, New York, 10032, United States|Columbia University Medical Center, Nephrology Clinical Research Center, New York, New York, 10032, United States Less << |
NCT04725812 | Preeclampsia|Severe Preeclamps... More >>ia|Eculizumab|HELLP|HELLP Syndrome|HELLP Syndrome Second Trimester|Pregnancy Related|AHUS|PNH|Complement Regulatory Factor Defect|Complement Abnormality|HELLP Syndrome Third Trimester Less << | PHASE2 | TERMINATED | 2021-12-07 | Cedars-Sinai Medical Center, L... More >>os Angeles, California, 90048, United States Less << |
NCT01303952 | Cold Agglutinin Disease | PHASE2 | COMPLETED | 2025-06-15 | Department of Hematology, Univ... More >>ersity Hospital Essen, Essen, 45122, Germany Less << |
NCT02029378 | Gullian Barre Syndrome | PHASE2 | UNKNOWN | 2025-03-16 | Southern General Hospital, Gla... More >>sgow, G51 4TF, United Kingdom Less << |
NCT02727608 | Diabetes Mellitus | PHASE2 | COMPLETED | 2025-06-18 | Dept of Surgical Sciences, Sec... More >>tion of Transplantation Surgery, University Hospital, Uppsala, 752 37, Sweden Less << |
NCT01095887 | Kidney Transplant | PHASE1|PHASE2 | TERMINATED | 2025-04-14 | Mayo Clinic, Rochester, Minnes... More >>ota, 55905, United States Less << |
NCT00098280 | Hemoglobinuria, Paroxysmal | PHASE3 | COMPLETED | 2025-02-06 | National Heart, Lung and Blood... More >> Institute (NHLBI), Bethesda, Maryland, 20892, United States Less << |
NCT02298933 | Thrombocytopenia|Alloimmune Pl... More >>atelet Refractoriness Less << | PHASE2 | COMPLETED | 2017-08-08 | National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less << |
NCT04346797 | SARS-CoV-2|COVID19 | PHASE2 | UNKNOWN | 2020-12-31 | Saint Louis, Paris, Ile De Fra... More >>nce, 75010, France|Réanimation médicale, Paris, 75010, France|saint Louis, Paris, 75010, France Less << |
NCT01194973 | Atypical Hemolytic-Uremic Synd... More >>rome Less << | PHASE2 | COMPLETED | 2025-02-14 | Burlington, Massachusetts, 018... More >>05, United States|Hackensack, New Jersey, 07601, United States|New York, New York, 10032, United States|Columbus, Ohio, 43210, United States|Houston, Texas, 77030, United States|Liège, 4020, Belgium|Caen, 14033, France|Lille, 59037, France|Nantes, 44093, France|Nice, 6000, France|Paris, 75743, France|Paris, 75970, France|Toulouse, 31059, France|Tours, 37044, France|Essen, 45147, Germany|Hannover, 30625, Germany|Bergamo, 24127, Italy|Firenze, 50134, Italy|Barcelona, 14004, Spain|Cordoba, 14004, Spain|Exeter, United Kingdom|London, United Kingdom|Newcastle, United Kingdom Less << |
NCT04288713 | Coronavirus | AVAILABLE | - | - | |
NCT00130000 | Paroxysmal Hemoglobinuria, Noc... More >>turnal Less << | PHASE3 | COMPLETED | 2007-06-25 | National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less << |
NCT00670774 | Kidney Transplant | PHASE1|PHASE2 | COMPLETED | 2025-08-17 | Mayo Clinic, Rochester, Minnes... More >>ota, 55905, United States Less << |
NCT01194804 | Paroxysmal Nocturnal Hemoglobi... More >>nuria Less << | PHASE2 | COMPLETED | 2025-03-11 | - |
NCT03722329 | Healthy | PHASE1 | COMPLETED | 2019-04-08 | PAREXEL International GmbH, Ea... More >>rly Phase Clinical Unit - Berlin, Berlin, 14050, Germany Less << |
NCT00844844 | Atypical Hemolytic Uremic Synd... More >>rome Less << | PHASE2 | COMPLETED | 2025-07-13 | Atlanta, Georgia, 30322, Unite... More >>d States|Fort Wayne, Indiana, 46804, United States|New York, New York, 10032, United States|New York, New York, 10065, United States|Grapevine, Texas, 76051, United States|Houston, Texas, 77030, United States|Innsbruck, 6020, Austria|Bordeaux, 33076, France|Lyon, 69437, France|Nantes, 44093, France|Paris, 75743, France|Quimper, 29107, France|Saint Priest en Jarez, 42270, France|Tours, 37044, France|Aachen, 52074, Germany|Essen, 45147, Germany|Newcastle, NE7 7DN, United Kingdom Less << |
NCT06513338 | Autoimmune Diseases | PHASE2 | COMPLETED | 2024-12-31 | Peking University First Hospit... More >>al, Beijing, 100038, China Less << |
NCT02013037 | Antibody-mediated Rejection|Hy... More >>peracute Rejection of Cardiac Transplant|Left Ventricular Dysfunction|Cardiac Allograft Vasculopathy|Heart Graft Dysfunction Less << | PHASE3 | COMPLETED | 2020-04-30 | Cedars Sinai Medical Center, H... More >>eart Institute, Los Angeles, California, 90048, United States Less << |
NCT01029587 | Antiphospholipid Antibody Synd... More >>rome|End Stage Renal Disease Less << | PHASE2 | COMPLETED | 2010-05-06 | Johns Hopkins University Schoo... More >>l of Medicine, Baltimore, Maryland, 21205, United States Less << |
NCT02093533 | Membranoproliferative Glomerul... More >>onephritis Less << | PHASE2 | COMPLETED | 2025-12-17 | Ospedale Pediatrico "Giovanni ... More >>XXIII" - U:O Nefrologia, Bari, BA, Italy|A.O. Papa Giovanni XXIII - U.O. Nefrologia e Dialisi/IRCCS IRFMN - Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Daccò, Bergamo, BG, Italy|Policlinico Sant'Orsola -Malpighi - U.O.S. Nefrologia e dialisi pediatrica, Bologna, BO, Italy|Policlinico "G.Martino" - U.O. Nefrologia e Dialisi, Messina, ME, Italy|Policlinico Universitario di Padova - U.O. Nefrologia Pediatrica, Padova, PD, Italy|Ospedale Centrale, Bolzano, 39100, Italy|Policlinico "Federico II" - U.O. Nefrologia, Napoli, Italy|Ospedale degli Infermi - U.O. Nefrologia e Dialisi, Rimini, Italy|C.I. Columbus-Università Cattolica del S.Cuore - UOC Nefrologia e Dialisi, Roma, Italy|Ospedale Pediatrico "Bambin Gesù" - U.O. Nefrologia, Roma, Italy|Presidio Ospedaliero O.I.R.M. "Sant'Anna" - U.O. Nefrologia, Torino, Italy|Ospedale "Santa Chiara" - U.O. Nefrologia, Trento, Italy|Ospedale Cà Foncello - U.O. Nefrologia, Treviso, Italy Less << |
NCT03518203 | Thrombotic Microangiopathies|A... More >>typical Hemolytic Uremic Syndrome|Multiple Organ Dysfunction Syndrome Less << | PHASE2 | COMPLETED | 2022-06-01 | Children's Hospital Los Angele... More >>s (CHLA), Los Angeles, California, 90027, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, 19104, United States Less << |
NCT04155424 | Neuromyelitis Optica|Neuromyel... More >>itis Optica Spectrum Disorder Less << | PHASE2|PHASE3 | TERMINATED | 2023-07-31 | Clinical Trial Site, San Franc... More >>isco, California, 94016, United States|Clinical Trial Site, Washington, District of Columbia, 20001, United States|Clinical Trial Site, Miami, Florida, 33101, United States|Clinical Trial Site, Atlanta, Georgia, 30301, United States|Research Site, Baltimore, Maryland, 21287, United States|Clinical Trial Site, Rockville, Maryland, 20847, United States|Clinical Trial Site, Boston, Massachusetts, 02101, United States|Research Site, Boston, Massachusetts, 02115, United States|Research Site, Saint Louis, Missouri, 63130, United States|Research Site, Hackensack, New Jersey, 07601, United States|Research Site, New Brunswick, New Jersey, 08901, United States|Research Site, New York, New York, 10016, United States|Clinical Trial Site, Chapel Hill, North Carolina, 27514, United States|Clinical Trial Site, Philadelphia, Pennsylvania, 19019, United States|Research Site, Dallas, Texas, 75390, United States|Research Site, Calgary, Alberta, T3B 6A8, Canada|Clinical Trial Site, Edmonton, Alberta, Canada|Research Site, Toronto, Ontario, M5G 1X8, Canada|Clinical Trial Site, Toronto, Ontario, Canada|Research Site, Montreal, Quebec, H3T1C5, Canada|Clinical Trial Site, Regensburger Stra?e, Goettingen, Germany|Research Site, Datteln, 45711, Germany|Research Site, Munster, 48149, Germany|Research Site, Catania, 95123, Italy|Research Site, Gallarate, 21013, Italy|Clinical Trial Site, Genoa, Italy|Research Site, Genova, 16132, Italy|Research Site, Rome, 00178, Italy|Clinical Trial Site, Rome, Italy|Research Site, Yokohama-shi, 232-0024, Japan|Clinical Trial Site, Yokohama, Japan|Clinical Trial Site, Seoul, Korea, Republic of|Clinical Trial Site, Barcelona, Spain|Research Site, Esplugues de Llobregat, 8950, Spain|Clinical Trial Site, Sevilla, Spain Less << |
NCT05886244 | Paroxysmal Nocturnal Hemoglobi... More >>nuria Less << | PHASE3 | ACTIVE_NOT_RECRUITING | 2025-06-13 | Research Site, Beijing, CN-100... More >>730, China|Research Site, Hangzhou, 310003, China|Research Site, Nantong, 226001, China|Research Site, Shanghai, 200040, China|Research Site, Tianjin, 300020, China|Research Site, Tianjin, 300052, China|Research Site, Wuhan, 430022, China Less << |
NCT03759366 | Myasthenia Gravis|Myasthenia G... More >>ravis, Juvenile Form|Myasthenia Gravis, Generalized Less << | PHASE3 | COMPLETED | 2023-11-06 | Research Site, Los Angeles, Ca... More >>lifornia, 90078, United States|Research Site, Tampa, Florida, 33612, United States|Research Site, Chicago, Illinois, 60611, United States|Research Site, Columbia, Missouri, 65201, United States|Research Site, Chapel Hill, North Carolina, 27599, United States|Research Site, Akron, Ohio, 44308, United States|Research Site, Philadelphia, Pennsylvania, 19104, United States|Research Site, Charleston, South Carolina, 29425, United States|Research Site, Iruma-Gun, 350-0495, Japan|Research Site, Itabashi-ku, 173-0003, Japan|Research Site, Shinjuku-ku, 162-8666, Japan Less << |
NCT02113891 | Subclinical Acute Antibody-med... More >>iated Rejection in Kidney Transplantation Less << | PHASE1|PHASE2 | WITHDRAWN | 2025-11-17 | - |
NCT00904826 | Neuromyelitis Optica|Devic's D... More >>isease Less << | PHASE1|PHASE2 | COMPLETED | 2025-12-11 | Mayo Clinic, Scottsdale, Arizo... More >>na, 85259, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States Less << |
NCT06764160 | Generalized Myasthenia Gravis ... More >>(gMG)|Refractory gMG Less << | PHASE3 | RECRUITING | 2026-12-21 | Research Site, Changchun, 1300... More >>21, China|Research Site, Changsha, 410008, China|Research Site, Fuzhou, 350001, China|Research Site, Guangzhou, 510080, China|Research Site, Guangzhou, 510620, China|Research Site, Qingdao, 266035, China|Research Site, Shanghai, 200040, China|Research Site, Shenzhen, 518053, China|Research Site, Suzhou, 215006, China|Research Site, Wuhan, 430030, China Less << |
NCT01106027 | Kidney Transplant | PHASE1|PHASE2 | TERMINATED | 2016-08-19 | Mayo Clinic, Rochester, Minnes... More >>ota, 55901, United States Less << |
NCT01399593 | Antibody Mediated Rejection | PHASE2 | TERMINATED | 2015-11-13 | Birmingham, Alabama, 35294, Un... More >>ited States|La Jolla, California, 92037, United States|Los Angeles, California, 90095, United States|San Francisco, California, 94143, United States|Washington, D.C., District of Columbia, 20007, United States|Atlanta, Georgia, 30309, United States|Chicago, Illinois, 60612, United States|Baltimore, Maryland, 21205, United States|Boston, Massachusetts, 02115, United States|Rochester, Minnesota, 55905, United States|Saint Louis, Missouri, 63110, United States|Livingston, New Jersey, 07039, United States|New York, New York, 10032, United States|Chapel Hill, North Carolina, 27599, United States|Cincinnati, Ohio, 45267, United States|Oklahoma City, Oklahoma, 73112, United States|Houston, Texas, 77030, United States|North Terrace, South Australia, 5000, Australia|Camperdown, 2050, Australia|Clayton VIC, 3168, Australia|Parkville VIC, 3050, Australia|Paris, 75010, France|Paris, 75743, France|Toulouse Cedex, 31059, France|Tours Cedex, 37044, France|Dresden, 01307, Germany|Heidelberg, 69120, Germany|Milan, 20162, Italy|Padova, 35128, Italy|Rotterdam, 3015 CE, Netherlands|Oslo, N-0027, Norway|Barcelona, 8036, Spain|G?teborg, 413 45, Sweden|Huddinge, SE 141 86, Sweden|Uppsala, S 751 85, Sweden|London, England, SE1 9RT, United Kingdom|London, England, W12 0HS, United Kingdom|Oxford, England, OX3 7LJ, United Kingdom|Birmingham, B15 2TH, United Kingdom|Cambridge, CB2 2QQ, United Kingdom|Coventry, CV2 2DX, United Kingdom Less << |
NCT01579838 | Chronic Hemolysis | PHASE1|PHASE2 | UNKNOWN | 2025-03-13 | Hadassah Medical Center, Jerus... More >>alem, 91120, Israel Less << |
NCT06453135 | Kidney Transplantation | PHASE1|PHASE2 | NOT_YET_RECRUITING | 2025-12-25 | West China Hospital, Sichuan U... More >>niversity, Chengdu, Sichuan, 610041, China Less << |
NCT00844545 | Atypical Hemolytic Uremic Synd... More >>rome Less << | PHASE2 | COMPLETED | 2025-07-13 | Atlanta, Georgia, 30322, Unite... More >>d States|Fort Wayne, Indiana, 46804, United States|New York, New York, 10032, United States|New York, New York, 10065, United States|Grapevine, Texas, 76051, United States|Houston, Texas, 77030, United States|Innsbruck, 6020, Austria|Bordeaux, 33076, France|Lyon, 69437, France|Nantes, 44093, France|Paris, 75743, France|Quimper, 29107, France|Saint Priest en Jarez, 42270, France|Tours, 37044, France|Aachen, 52074, Germany|Essen, 45147, Germany|Newcastle, NE7 7DN, United Kingdom Less << |
NCT01193348 | Atypical Hemolytic-Uremic Synd... More >>rome Less << | PHASE2 | COMPLETED | 2025-04-14 | Atlanta, Georgia, 30322, Unite... More >>d States|Hackensack, New Jersey, 07601, United States|Corpus Christi, Texas, 78411, United States|Spokane, Washington, 99204, United States|North Adelaide, South Australia, 5006, Australia|Gent, 9000, Belgium|Toronto, Ontario, M5G1X8, Canada|Lille, 59800, France|Marseille, 13385, France|Paris, 75935, France|Rouen, 76000, France|Hannover, 30625, Germany|Milano, Italy|Palermo, 90134, Italy|Nijmegen, 6525, Netherlands|London, United Kingdom|Nottingham, United Kingdom Less << |
NCT05876351 | Atypical Hemolytic Uremic | PHASE3 | ACTIVE_NOT_RECRUITING | 2025-05-19 | Research Site, Beijing, 100034... More >>, China|Research Site, Beijing, 100045, China|Research Site, Changsha, 410007, China|Research Site, Qingdao, 110016, China|Research Site, Taiyuan, 030012, China|Research Site, Wuhan, 430030, China Less << |
NCT04103489 | HELLP Syndrome (HELLP), Third ... More >>Trimester|Complement Abnormality|Morbidity;Newborn|Maternal Injury|Preeclampsia Severe Less << | PHASE1 | COMPLETED | 2023-09-04 | The Johns Hopkins University, ... More >>Baltimore, Maryland, 21287, United States Less << |
NCT01757431 | Atypical Hemolytic Uremic Synd... More >>rome (aHUS) Less << | PHASE2 | COMPLETED | 2013-09-25 | Nagano Red Cross Hospital, Nag... More >>ano, Japan|Tokyo Medical and Dental University Hospital, Tokyo, Japan Less << |
NCT00867932 | Hemoglobinuria, Paroxysmal | PHASE4 | COMPLETED | 2011-05-12 | Orange, California, 92868, Uni... More >>ted States|Pensacola, Florida, 32504, United States|Memphis, Tennessee, 38105, United States Less << |
Tags: Eculizumab | Anti-Human C5, Humanized Antibody | Complement System/monoclonal antibody | Complement System | Immunology/Inflammation | Human Inhibitory Monoclonal Antibody | Tumor Development and Microenvironment Evolution | 219685-50-4
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL